Clinical trial
Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating…
NCT00025545 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00025545 |
|---|---|
| Title | Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> |
| Official title | A Phase II Trial to Evaluate the Use of G-CSF-Mobilized Peripheral Blood Progenitor Cells as Hematopoietic Rescue in Patients With Acute Leukemia Undergoing Allografting From an Unrelated Donor |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, methotrexate, peripheral blood stem cell transplantation, radiation therapy |
| Start date | Mar 1, 1996 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | Jun 20, 2003 |
| Last update posted | May 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: